National Institutes of Health Consensus Development Conference Consensus Statement. Clinical use of botulinum toxin. Bethesda, Md.: National Institutes of Health, 1990; 8: 1–20.
2.
FordCNBlessDMLoweryJD. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia. Otolaryngol Head Neck Surg1990; 103: 752–8.
3.
GreenDCBerkeGSWardPHGerrattBR. Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia. Ann Otol Rhinol Laryngol1992; 101: 883–7.
4.
BlitzerABrinMFFahnSLovelaceRE. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope1988; 98: 193–7.